Navigation Links
Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing

BEIJING and CLAREMONT, Calif., Jan. 17 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (KWBT.OB) has completed its annual management meetings including yearend business review, planning for 2008 and employee recognition ceremonies. The meetings commenced in Xiaotangshan, Beijing on January 11, 2008.

Attending were over 50 managers and staff from Kiwa's corporate headquarters in Beijing, and department managers of Kiwa Shandong and Tianjing Kiwa. During the sessions, company management team members gave speeches reviewing achievements in the past year for their departments. Acknowledgment was made of the comprehensive achievements of Kiwa's employees in 2007: significant improvements in revenues, improvements in operating efficiency and margins, updating of the bio-fertilizer factory, development, testing and approval of new products and expanded distribution and marketing efforts.

In addition, management set forth the business goals and described the main tasks for 2008. They outlined the objectives and strategic plans for the year for Kiwa Shandong, Tianjin Kiwa, bio-technology research and development, building the distribution network, financial management, and corporate management targets were set with the expectation of continuing and expanding on the progress of the past year.

During the session, the efforts of 28 individuals was recognized: 4 staff were awarded "Honor for Striving for Kiwa"; 8 staff were awarded as "Prominent Contributor"; 5 were awarded as "Best New Seller"; 11 staff were awarded as "Advanced Worker"; 2 were awarded "Honor for Loyalty". Lastly, representatives of the honored individuals gave speeches expressing their confidence in the bright future of the Company and pledged to work harder to achieve the objectives set forth for 2008.

Mr. Wei Li, Board Chairman and CEO of Kiwa, stated: "The 2007 annual management meeting is the summary of last year and the blueprint for the next year. We were pleased to recognize employees and managers who helped Kiwa achieve excellent results in 2007. This meeting was also the chance to focus everyone on the great development opportunities for Kiwa in 2008. We will continuously and collectively strive for our objective with good faith to create outstanding achievements in 2008."

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( ) or visit the Company's website at .

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward- looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

For more information, please contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

Tel: +1-626-715-5855


Robert Schechter

Equity Communications

Tel: +1-212-499-6809


SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
2. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
3. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
4. So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market
5. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
6. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
7. Kiwa Bio-Tech Products Group Holds a Fertilizer Products Exhibition in Hebei
8. CTDC Holds a Ribbon Cutting Ceremony to Showcase First SnO2 Production Line
9. Society for Biological Engineering Holds First International Conference on Stem Cell Engineering
10. Annual General Meeting ("AGM") and Extraordinary General Meeting ("EGM") Notices Posted to Shareholders
11. Sinovac Announces Postponement of Annual General Meeting
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Global ... Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group GMP ... a world-class team of qualified medical researchers and practitioners, experienced in administering stem ...
(Date:11/30/2015)... interventional radiology technique shows promise for helping morbidly obese patients ... being presented today at the annual meeting of the Radiological ... --> --> Gastric artery ... a way to stop bleeding in emergency situations, but the ... obesity is new. Mubin Syed , M.D., interventional ...
(Date:11/30/2015)... , December 1, 2015 Partnership includes ... for the u niversity , ... support treatment s cale - up ... (ARVs)   Africa , where licensees based anywhere in ... based on SDN technology. --> Africa , where licensees based ...
(Date:11/30/2015)... Mass. , Nov. 30, 2015 ... HART ), a biotechnology company developing bioengineered organ ... received written notification from The NASDAQ Stock Market ... bid price requirements. The letter noted that as ... HART,s common stock having exceeded $1.00 per share ...
Breaking Biology Technology:
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):